The Molecular and Cellular Pharmacology Ph.D. Program
Molecular and Cellular Pharmacology is an interdepartmental Graduate Program with faculty from the Department of Pharmacological Sciences, other Departments at Stony Brook and scientists from Brookhaven National Laboratories and Cold Spring Harbor Laboratories. It offers a comprehensive research and educational experience ranging from the basic biological sciences to the imaging of biological processes in cell and tissue cultures and mammals. The research interests of our training faculty include the therapeutics of cancer and infectious diseases, cardiovascular and endocrine pharmacology, neuropharmacology and drug design. The coursework in the program provides advanced knowledge in pharmacology and in biochemistry, molecular genetics, cell biology, immunology, structural and computational biology and neuropharmacology.
The quality of the education and training offered by our Program is reflected by 41 years of continuous NIH-funded training grant support, the participation of many affiliated faculty outside of the core department and outstanding outcomes for more than 140 PhD graduates who hold academic positions at top Universities and in the pharmaceutical industry. In the last fifteen years, we have graduated 61 students, with an average time to degree of 4.9 years, with over 90% of our students graduating in no more than 6 years after entering the program.
Our goal is to provide education, support and a training environment that successfully prepares students for subsequent academic or industrial career opportunities.
The MCP graduate program consider all candidates equally, regardless of state of residence, and particularly encourages applications from women, individuals with disabilities, and members of racial and/or ethnic groups currently under-represented in biomedical science.
We are looking forward to meeting you.
Dr. Holly Colognato
Director, Molecular and Cellular Pharmacology Ph.D. Graduate Program